Abstract:Hepatic encephalopathy (HE) is a neuropsychiatric syndrome that develops in patients with severe liver dysfunction and/or portocaval shunting. Despite more than a century of research into the relationship between liver damage and development of encephalopathy, pathogenetic mechanisms of hepatic encephalopathy have not yet been fully elucidated. It is generally recognized, however, that the main trigger of neurologic complications in hepatic encephalopathy is the neurotoxin ammonia/ammonium, concentration of which in the blood increases to toxic levels (hyperammonemia), when detoxification function of the liver is impaired. Freely penetrating into brain cells and affecting NMDA-receptor-mediated signaling, ammonia triggers a pathological cascade leading to the sharp inhibition of aerobic glucose metabolism, oxidative stress, brain hypoperfusion, nerve cell damage, and formation of neurological deficits. Brain hypoperfusion, in turn, could be due to the impaired oxygen transport function of erythrocytes, because of the disturbed energy metabolism that occurs in the membranes and inside erythrocytes and controls affinity of hemoglobin for oxygen, which determines the degree of oxygenation of blood and tissues. In our recent study, this causal relationship was confirmed and novel ammonium-induced pro-oxidant effect mediated by excessive activation of NMDA receptors leading to impaired oxygen transport function of erythrocytes was revealed. For a more complete evaluation of "erythrocytic" factors that diminish brain oxygenation and lead to encephalopathy, in this study, activity of the enzymes and concentration of metabolites of glycolysis and Rapoport–Lubering shunt, as well as morphological characteristics of erythrocytes from the rats with acute hyperammoniemia were determined. To elucidate the role of NMDA receptors in the above processes, MK-801, a non-competitive receptor antagonist, was used. Based on the obtained results it can be concluded that it is necessary to consider ammonium-induced morphofunctional disorders of erythrocytes and hemoglobinemia which can occur as a result of alterations in highly integrated networks of metabolic pathways may act as an additional systemic "erythrocytic" pathogenetic factor to prevent the onset and progression of cerebral hypoperfusion in hepatic encephalopathy accompanied by hyperammonemia.

Modulation of brain energy metabolism in hepatic encephalopathy: impact of glucose metabolic dysfunction

Navigating the Gut-brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy

Characteristic Metabolic Alterations Identified in Primary Neurons under High Glucose Exposure

Sugar for the brain: the role of glucose in physiological and pathological brain function

Glucose metabolic crosstalk and regulation in brain function and diseases

Hepatic encephalopathy as a result of ammonia-induced increase in GABAergic tone with secondary reduced brain energy metabolism

NMDA Receptors and Indices of Energy Metabolism in Erythrocytes: Missing Link to the Assessment of Efficiency of Oxygen Transport in Hepatic Encephalopathy

Abnormal brain oxygen homeostasis in an animal model of liver disease

Brain Metabolism in Health and Neurodegeneration: The Interplay Among Neurons and Astrocytes

Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming

The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction

The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy

Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

Aberrant Energy Metabolism in Alzheimer's Disease

The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Aberrant Energy Metabolism in Alzheimer’s Disease

Decoding Alzheimer's Disease from Perturbed Cerebral Glucose Metabolism: Implications for Diagnostic and Therapeutic Strategies

Hyperammonemia in Hepatic Encephalopathy

Elucidating hippocampal proteome dynamics in moderate hepatic encephalopathy rats: insights from high-resolution mass spectrometry

Diet-induced metabolic disturbances as modulators of brain homeostasis.